Literature DB >> 21494012

Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism.

Hwei-Hsien Chen1, Shiau-Chin Lin, Ming-Huan Chan.   

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The aim of the present study was to investigate the protective and restorative potential of magnolol, a major bioactive biphenolic from the bark of Magnolia officinalis, for alleviating the motor deficits induced by 6-hydroxydopamine (6-OHDA) in a mouse model of PD. Before or after unilateral striatal 6-OHDA lesion induction, mice were administered magnolol subchronically; then the apomorphine-induced rotational behaviors of the hemiparkinsonian mice and tyrosine hydroxylase (TH) expression in striatum were determined. Magnolol that was administered 30 min before 6-OHDA lesion induction and then applied daily for 14 days significantly ameliorated apomorphine-induced contralateral rotation in 6-OHDA-lesioned mice, and consistently protected the decreased levels of TH protein expression in striatum. One week after termination of the 7-day subchronic pretreatment, magnolol also remarkably prevented the dopaminergic neuronal loss as identified by TH immunohistochemistry staining in striatum, associated with rotational behavioral protection in 6-OHDA-lesioned mice. Importantly, daily subchronic posttreatment with magnolol for 14 days efficiently reduced apomorphine-induced rotation, but did not restore the neuronal impairment in striatum damaged by 6-OHDA. Taken together, these findings suggest that magnolol may possess neuronal protective activity and behavioral restoration against 6-OHDA-induced toxicity in the PD model.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494012     DOI: 10.1159/000323872

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  7 in total

1.  Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders.

Authors:  Shun Zhu; Fang Liu; Ruiyuan Zhang; Zongxiang Xiong; Qian Zhang; Li Hao; Shiyin Chen
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

2.  Botanical Polyphenols Mitigate Microglial Activation and Microglia-Induced Neurotoxicity: Role of Cytosolic Phospholipase A2.

Authors:  Dennis Y Chuang; Agnes Simonyi; Jiankun Cui; Dennis B Lubahn; Zezong Gu; Grace Y Sun
Journal:  Neuromolecular Med       Date:  2016-06-23       Impact factor: 3.843

3.  Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease.

Authors:  Akiko Muroyama; Aya Fujita; Cheng Lv; Shota Kobayashi; Yoshiyasu Fukuyama; Yasuhide Mitsumoto
Journal:  Parkinsons Dis       Date:  2012-05-08

Review 4.  Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease.

Authors:  Sandeep Vasant More; Hemant Kumar; Seong Mook Kang; Soo-Yeol Song; Kippeum Lee; Dong-Kug Choi
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-01       Impact factor: 2.629

5.  Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.

Authors:  Chi-Chang Weng; Zi-An Chen; Ko-Ting Chao; Ting-Wei Ee; Kun-Ju Lin; Ming-Huan Chan; Ing-Tsung Hsiao; Tzu-Chen Yen; Mei-Ping Kung; Ching-Han Hsu; Shiaw-Pyng Wey
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

Review 6.  Neurotransmitters and molecular chaperones interactions in cerebral malaria: Is there a missing link?

Authors:  Michael Oluwatoyin Daniyan; Funmilola Adesodun Fisusi; Olufunso Bayo Adeoye
Journal:  Front Mol Biosci       Date:  2022-08-24

7.  Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells.

Authors:  Dennis Y Chuang; Ming-Huan Chan; Yijia Zong; Wenwen Sheng; Yan He; Jing Hua Jiang; Agnes Simonyi; Zezong Gu; Kevin L Fritsche; Jiankun Cui; James C Lee; William R Folk; Dennis B Lubahn; Albert Y Sun; Grace Y Sun
Journal:  J Neuroinflammation       Date:  2013-01-29       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.